Abdominal obesity and the metabolic syndrome: a surgeon's perspective.
Over the past decade, a major shift in the clinical risk factors in the population undergoing a cardiac surgery has been observed. In the general population, an increasing prevalence of obesity has largely contributed to the development of cardiovascular disorders. Obesity is a heterogeneous condition in which body fat distribution largely determines metabolic perturbations. Consequently, individuals characterized by increased abdominal fat deposition and the so-called metabolic syndrome (MetS) have a higher risk of developing coronary artery disease. Recent studies have also emphasized that visceral obesity is a strong risk factor for the development of heart valve diseases. In fact, individuals characterized by visceral obesity and its metabolic consequences, such as the small dense low-density lipoprotein phenotype, have a faster progression rate of aortic stenosis, which is related to increased valvular inflammation. Furthermore, the degenerative process of implanted bioprostheses is increased in subjects with the MetS and/or diabetes, suggesting that a process akin to atherosclerosis could be involved in the failure of bioprostheses. In addition to being an important risk factor for the development of cardiovascular disorders, the MetS is increasing the operative mortality risk following coronary artery bypass graft surgery. Thus, recent evidence supports visceral obesity as a global risk factor that is affecting the development of many heart disorders, and that is also impacting negatively on the results of patients undergoing surgical treatment for cardiovascular diseases. In the present paper, recent concepts surrounding the MetS and its implications in various cardiovascular disorders are reviewed along with the clinical implications.
Mathieu
Patrick
P
Laval Hospital, Department of Surgery, Laval University, Sainte-Foy, Quebec. patrick.mathieu@chg.ulaval.ca
D006348:Cardiac Surgical Procedures / Q000379:methods*; D006331:Heart Diseases / Q000453:epidemiology / Q000209:etiology / Q000601:surgery*; D006801:Humans; D024821:Metabolic Syndrome / Q000150:complications* / Q000453:epidemiology; D009017:Morbidity; D009765:Obesity / Q000150:complications* / Q000453:epidemiology; D011379:Prognosis; D012307:Risk Factors
J Am Coll Cardiol. 2006 Jun 6;47(11):2229-36
16750688
J Investig Med. 2007 Sep;55(6):284-91
17963677
J Am Diet Assoc. 2007 Nov;107(11):1966-72
17964317
Am J Physiol Endocrinol Metab. 2005 Jan;288(1):E216-21
15367397
Circulation. 2007 Sep 11;116(11 Suppl):I213-9
17846306
J Am Coll Cardiol. 1997 Mar 1;29(3):630-4
9060903
Am J Cardiol. 2003 Dec 15;92(12):1479-82
14675593
Arch Intern Med. 2005 Apr 25;165(8):858-62
15851635
Diabetes Metab. 1999 Sep;25(3):199-211
10499189
Ann Intern Med. 2006 Oct 3;145(7):554-5; author reply 555
17015879
J Atheroscler Thromb. 2002;9(6):266-75
12560585
Heart. 2006 Dec;92(12):1844-9
16709694
Biochimie. 2005 Jan;87(1):57-64
15733738
J Am Coll Cardiol. 2007 Aug 28;50(9):843-51
17719470
Annu Rev Med. 2002;53:319-36
11818477
Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):187-93
17975118
N Engl J Med. 2005 Jun 9;352(23):2389-97
15944423
Ann Intern Med. 2006 Apr 4;144(7):517-24
16585666
J Clin Endocrinol Metab. 2000 Jul;85(7):2378-84
10902782
J Am Coll Cardiol. 2007 Feb 6;49(5):554-61
17276178
Comp Biochem Physiol B. 1989;94(2):225-32
2591189
Heart. 2003 Jul;89(7):767-72
12807853
Nature. 2006 Dec 14;444(7121):881-7
17167477
J Heart Valve Dis. 2005 May;14(3):353-7
15974530
J Biomed Mater Res. 1994 Jan;28(1):35-47
8126027
Circulation. 2002 Oct 22;106(17):2224-30
12390952
Ital Heart J. 2004 Feb;5(2):85-8
15086137
Rev Port Cardiol. 2007 Jan;26(1):51-62
17427836
J Thorac Cardiovasc Surg. 2003 Oct;126(4):969-75
14566234
Circulation. 2006 Jul 25;114(4):318-27
16831988
Trends Endocrinol Metab. 2003 Nov;14(9):398-403
14580758
Atherosclerosis. 2002 Jun;162(2):363-71
11996956
Circulation. 2004 Sep 7;110(10):1291-5
15337704
Circulation. 1994 Aug;90(2):844-53
7519131
Ann Thorac Surg. 2005 Mar;79(3):1072-80
15734452
Circulation. 2006 Jul 4;114(1 Suppl):I512-7
16820629
Hypertension. 2005 Jun;45(6):1031-4
15897372
Cardiovasc Diabetol. 2006 Jan 13;5:1
16412224
J Atheroscler Thromb. 2005;12(6):295-300
16394610
Atherosclerosis. 1992 Apr;93(3):189-99
1590824
Eur J Cardiothorac Surg. 2004 Mar;25(3):364-70
15019662
Atherosclerosis. 1996 Jun;123(1-2):43-56
8782836
Curr Opin Lipidol. 2007 Oct;18(5):483-91
17885417
Nat Clin Pract Cardiovasc Med. 2007 Apr;4(4):192-3
17297484
J Am Coll Cardiol. 2002 Nov 20;40(10):1723-30
12446053
J Am Coll Cardiol. 1993 Apr;21(5):1220-5
8459080
Int J Biochem Cell Biol. 2008;40(5):821-36
18201922
Can J Cardiol. 2007 Oct;23 Suppl B:32B-39B
17932585